A. Moazzam, J. Drappatz, and K. Ry&kesari, Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review, Journal of Neuro-Oncology, vol.45, issue.9, pp.185-200, 2012.
DOI : 10.1080/1042819042000219430

L. Simon, A. Fitsiori, and R. Lemal, Bing-Neel syndrome, a rare complication of Waldenstrom macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)., Haematologica, vol.100, issue.12, pp.1587-94, 2015.
DOI : 10.3324/haematol.2015.133744

S. Quijano, A. Lopez, M. Sancho, and J. , Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry, Journal of Clinical Oncology, vol.27, issue.9, pp.1462-1471, 2009.
DOI : 10.1200/JCO.2008.17.7089

A. Korfel, M. Nowosielski, and J. Pardo-moreno, How to facilitate early diagnosis of CNS involvement in malignant lymphoma, Expert Review of Hematology, vol.329, issue.1, pp.1081-91, 2016.
DOI : 10.1093/neuonc/nou089

S. Fisson, H. Ouakrim, and V. Touitou, Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis, PLoS ONE, vol.42, issue.2, pp.52385-52393, 2013.
DOI : 10.1371/journal.pone.0052385.t001

M. Costopoulos, V. Touitou, and J. Golmard, ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis, Ophthalmology, vol.123, issue.7, 2016.
DOI : 10.1016/j.ophtha.2016.01.037
URL : https://hal.archives-ouvertes.fr/hal-01290416

C. Chan and S. Whitcup, Interleukin-10 in the Vitreous of Patients With Primary Intraocular Lymphoma, American Journal of Ophthalmology, vol.120, issue.5, pp.671-674, 1995.
DOI : 10.1016/S0002-9394(14)72217-2

J. Rubenstein, V. Wong, and C. Kadoch, CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma, Blood, vol.121, issue.23, pp.4740-4748, 2013.
DOI : 10.1182/blood-2013-01-476333

Y. Sasagawa, T. Akai, and T. O&iizuka, Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system, Journal of Neuro-Oncology, vol.99, issue.Suppl 2, pp.177-83, 2015.
DOI : 10.1159/000236329

L. Nguyen-them, M. Costopoulos, and M. Tanguy, The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients, European Journal of Cancer, vol.61, pp.69-76, 2016.
DOI : 10.1016/j.ejca.2016.03.080

Y. Song, W. Zhang, and L. Zhang, Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma, Scientific Reports, vol.470, issue.1, pp.38671-38685, 2016.
DOI : 10.1038/nature09671
URL : http://www.nature.com/articles/srep38671.pdf

S. Whitcup, V. Stark-vancs, and R. Wittes, Association of Interleukin 10 in the Vitreous and Cerebrospinal Fluid and Primary Central Nervous System Lymphoma, Archives of Ophthalmology, vol.115, issue.9, pp.1157-60, 1997.
DOI : 10.1001/archopht.1997.01100160327010

T. Sasayama, S. Nakamizo, and M. Nishihara, Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL), Neuro-Oncology, vol.14, issue.3, pp.368-80, 2012.
DOI : 10.1093/neuonc/nor203

M. Minnema, E. Kimby, D. Sa, and S. , Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome, Haematologica, vol.102, issue.1, pp.43-51, 2017.
DOI : 10.3324/haematol.2016.147728
URL : https://hal.archives-ouvertes.fr/hal-01471557

S. Elsawa, A. Novak, and S. Ziesmer, Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity, Blood, vol.118, issue.20, pp.5540-5549, 2011.
DOI : 10.1182/blood-2011-04-351742

C. Muniz, L. Martin-martin, and A. Lopez, Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome, Blood, vol.123, issue.12, pp.1864-1873, 2014.
DOI : 10.1182/blood-2013-11-537993

A. Grelier, L. Garff-tavernier, M. Nauwelaers, F. , and S. M&merle, Soluble CD23 measurement by CBA: A convenient and reliable quantification method in Chronic Lymphocytic Leukemia, Cytometry Part B: Clinical Cytometry, vol.86, pp.91-98, 2014.
DOI : 10.1002/cytob.21135